X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10798) 10798
Book Review (3795) 3795
Publication (723) 723
Newsletter (246) 246
Book / eBook (174) 174
Book Chapter (33) 33
Conference Proceeding (20) 20
Magazine Article (9) 9
Dissertation (6) 6
Transcript (4) 4
Newspaper Article (3) 3
Web Resource (3) 3
Reference (2) 2
Report (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10168) 10168
humans (9849) 9849
female (5539) 5539
oncology (4923) 4923
male (4457) 4457
chemotherapy (3917) 3917
middle aged (3684) 3684
adult (3469) 3469
cancer (3468) 3468
aged (2941) 2941
antineoplastic combined chemotherapy protocols - therapeutic use (2590) 2590
antineoplastic agents - adverse effects (2340) 2340
antineoplastic agents - therapeutic use (2159) 2159
treatment outcome (2060) 2060
antineoplastic agents, alkylating - adverse effects (1962) 1962
antineoplastic combined chemotherapy protocols - adverse effects (1839) 1839
animals (1829) 1829
hematology (1743) 1743
antineoplastic agents (1590) 1590
care and treatment (1586) 1586
antineoplastic agents, alkylating - therapeutic use (1407) 1407
pharmacology & pharmacy (1331) 1331
antimitotic agents (1283) 1283
antineoplastic agents, alkylating - administration & dosage (1283) 1283
medicine & public health (1258) 1258
neoplasms - drug therapy (1243) 1243
therapy (1187) 1187
adolescent (1167) 1167
cyclophosphamide (1090) 1090
combined modality therapy (1088) 1088
research (1050) 1050
child (1012) 1012
antineoplastic agents - administration & dosage (967) 967
drug therapy (937) 937
health aspects (931) 931
prognosis (921) 921
aged, 80 and over (909) 909
disease-free survival (906) 906
radiotherapy (888) 888
dacarbazine - analogs & derivatives (878) 878
risk factors (878) 878
retrospective studies (863) 863
cyclophosphamide - administration & dosage (852) 852
abridged index medicus (791) 791
analysis (780) 780
drug administration schedule (759) 759
antineoplastic combined chemotherapy protocols - administration & dosage (753) 753
cyclophosphamide - adverse effects (753) 753
temozolomide (749) 749
breast neoplasms - drug therapy (745) 745
antineoplastic agents - pharmacology (738) 738
dose-response relationship, drug (727) 727
brain neoplasms - drug therapy (717) 717
toxicity (716) 716
tumors (687) 687
follow-up studies (678) 678
survival analysis (671) 671
transplantation (667) 667
mice (659) 659
hematology, oncology and palliative medicine (656) 656
survival rate (654) 654
child, preschool (631) 631
survival (625) 625
neoplasm staging (614) 614
clinical trials as topic (603) 603
phase-ii trial (571) 571
young adult (566) 566
multiple myeloma - drug therapy (556) 556
dacarbazine - therapeutic use (555) 555
breast cancer (553) 553
time factors (551) 551
dacarbazine - adverse effects (549) 549
trial (546) 546
leukemia (524) 524
stem-cell transplantation (518) 518
cisplatin (517) 517
phase-ii (505) 505
multiple myeloma (482) 482
clinical trials (479) 479
radiotherapy - adverse effects (473) 473
breast-cancer (466) 466
article (464) 464
children (442) 442
dosage and administration (439) 439
clinical neurology (436) 436
apoptosis (434) 434
doxorubicin - administration & dosage (425) 425
internal medicine (414) 414
dacarbazine - administration & dosage (411) 411
rituximab (411) 411
prospective studies (408) 408
glioblastoma (406) 406
infant (403) 403
remission induction (402) 402
drug therapy, combination (401) 401
recurrence (401) 401
surgery (401) 401
bone-marrow-transplantation (400) 400
pharmacology/toxicology (399) 399
cisplatin - administration & dosage (391) 391
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (126) 126
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Online Resources - Online (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Chemistry (A D Allen) - Stacks (3) 3
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10929) 10929
French (87) 87
German (51) 51
Japanese (51) 51
Russian (39) 39
Spanish (23) 23
Polish (16) 16
Chinese (15) 15
Italian (8) 8
Hungarian (6) 6
Norwegian (6) 6
Dutch (5) 5
Czech (4) 4
Danish (3) 3
Finnish (3) 3
Hebrew (2) 2
Swedish (2) 2
Ukrainian (2) 2
Croatian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10028, pp. 1629 - 1637
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2014, Volume 61, Issue 1, pp. 53 - 67
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1873 - 1883
Summary Background Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based... 
Internal Medicine | BENDAMUSTINE | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CLL | CYCLOPHOSPHAMIDE | CHEMOIMMUNOTHERAPY | RITUXIMAB | MONOCLONAL-ANTIBODIES | ELDERLY-PATIENTS | FLUDARABINE | HUMAN CD20 | Age Distribution | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Chlorambucil - adverse effects | Prospective Studies | Chlorambucil - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Aged, 80 and over | Adult | Female | Chlorambucil - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Antineoplastic Agents, Alkylating - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Distribution | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Antineoplastic Agents, Alkylating - adverse effects | Chlorambucil | Medical colleges | Hospitals | Comorbidity | United Kingdom | Product development | India | Medical research | Flow cytometry | Immunoglobulins | Medical imaging | Laboratories | Cytotoxicity | Infections | Ovarian cancer | Bone marrow | Drug dosages | Age | Binding sites | Geriatrics | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 26, pp. 2517 - 2526
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2015, Volume 33, Issue 12, pp. 1325 - 1333
Journal Article
JAMA, ISSN 0098-7484, 06/2014, Volume 311, Issue 23, pp. 2397 - 2405
Journal Article